arrow
Y

Yukitaka Ueki

leiden university
H指数:40
被引数:5,837
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cytokine/chemokine profiles in rheumatoid arthritis patients who failed Boolean remission solely due to elevated patient global assessment

类风湿关节炎患者中仅因患者总体评估升高而未达到布尔缓解的细胞因子/趋化因子谱

2026-02-010
PRE
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis

类风湿关节炎中按干扰素谱和自身抗体分层的治疗效果

2025-09-300
PRE
Effectiveness of Etanercept Biosimilar Initiating for Etanercept-Naive Patients, Using Ultrasound, Clinical, and Biomarker Assessments in Outcomes of Real-World Therapy (ENPORT-NGSK Study): An Interventional, Multicenter, Open-Label, Single-Arm Clinical Trial
2025-03-010
OAAI
Impact of Janus kinase inhibitors and methotrexate on interstitial lung disease in rheumatoid arthritis patients
2024-12-160
OAAI
Impact of SARS-CoV-2 mRNA vaccine on arthritis condition in rheumatoid arthritis
2023-08-251
OAAI
Immune complexome analysis of a rich variety of serum immune complexes identifies disease-characteristic immune complex antigens in systemic sclerosis
2023-01-011
OA
The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study
2022-05-062
OAAI
Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia
2022-02-247
OAAI
Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis
2020-06-118
OAAI
Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan
2018-11-2822
PREAI
Brief Report: Attenuated Effectiveness of Tumor Necrosis Factor Inhibitors for Anti-Human T Lymphotropic Virus Type I Antibody-Positive Rheumatoid Arthritis
2018-05-2517
PREAI
Bioanalysis of bevacizumab and infliximab by high-temperature reversed-phase liquid chromatography with fluorescence detection after immunoaffinity magnetic purification
2016-04-0128
PREAI
PROGNOSTIC FACTORS TOWARD RAPID RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE: A JAPANESE MULTICENTER, PROSPECTIVE LONGITUDINAL COHORT STUDY FOR ACHIEVING TREAT TO TARGET STRATEGY
2015-06-010
PREAI
EARLY DIAGNOSIS IS ASSOCIATED WITH THE LESS FLAIR IN PATIENTS WITH REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA (RS3PE) SYNDROME
2015-06-010
PREAI
Baseline characteristics and tocilizumab therapy for patients with RA who were registered in the ACTRA-RI study (n=405)
2015-03-0133
OAAI
Increased prevalence of MEFV exon 10 variants in Japanese patients with adult-onset Still's disease

日本成年发作的斯蒂尔氏病患者中MEFV外显子10变体的患病率增加

2015-02-1625
OAAI
MEFV AND TNFRSF1A GENE MUTATIONS IN PATIENTS WITH INFLAMMATORY MYOPATHY WITH ABUNDANT MACROPHAGES
2014-06-010
PREAI
EVALUATION OF THE JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) OF RAPID RADIOGRAPHIC PROGRESSION (RRP) TREATED WITH SYNTHETIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARDS) IN DAILY PRACTICE: A LARGE-SCALE PROSPECTIVE LONGITUDINAL COHORT STUDY
2014-06-011
PRE
SURVEILLANCE OF THE OUTCOME OF REMITTING SERONEGATIVE SYMMETRICAL SYNOVITIS WITH PITTING EDEMA (RS3PE) SYNDROME
2014-06-011
PREAI